IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,031,038 | +1.6% | 159,678 | +19.1% | 0.03% | +21.4% |
| Q3 2022 | $5,938,000 | -35.1% | 134,081 | -55.4% | 0.03% | -9.7% |
| Q4 2021 | $9,153,000 | +2592.1% | 300,797 | +3426.3% | 0.03% | +3000.0% |
| Q2 2021 | $340,000 | +33.9% | 8,530 | +50.7% | 0.00% | 0.0% |
| Q1 2021 | $254,000 | +16.0% | 5,659 | +46.3% | 0.00% | 0.0% |
| Q4 2020 | $219,000 | -95.0% | 3,867 | -95.8% | 0.00% | -96.9% |
| Q3 2020 | $4,363,000 | +801.4% | 91,956 | +1020.0% | 0.03% | +700.0% |
| Q2 2020 | $484,000 | -92.5% | 8,210 | -91.8% | 0.00% | -91.8% |
| Q2 2019 | $6,420,000 | +235.2% | 99,891 | +316.0% | 0.05% | +308.3% |
| Q1 2019 | $1,915,000 | +258.6% | 24,011 | +98.2% | 0.01% | +300.0% |
| Q1 2018 | $534,000 | – | 12,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |